While there is currently no cure for fatty liver disease (FLD) or nonalcoholic steatohepatitis (NASH), a condition to which FLD can lead, the pharmaceutical industry is turning to clinical research […]
The U.S. Food and Drug Administration (FDA) is taking a look in the mirror as the new year gets under way, and is liking most of what it sees. Working […]
ACRP Executive Director Jim Kremidas discusses the important role workforce diversity can play in clinical trial participation in this December 30 segment with NPR's Marketplace.